{"id":"W4303983518","doi":"10.1097/01.hs9.0000890604.66330.a0","title":"P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Brentuximab vedotin; Dacarbazine; ABVD; Medicine; Hazard ratio; Internal medicine; Vinblastine; Oncology; Population; Progression-free survival; Vincristine; Lymphoma; Confidence interval; Surgery; Chemotherapy; Hodgkin lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002057341,0.0003040339,0.0008096151,0.0003199125,0.000108841,0.0005722992,0.0004254137,0.0002684229,0.001946336],"category_scores_gemma":[0.001832836,0.0001361852,0.001178868,0.0005645598,0.0001813901,0.0005046216,0.0003387351,0.0006707793,0.0002135607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005009042,"about_ca_system_score_gemma":0.0005682925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008055154,"about_ca_topic_score_gemma":0.002988217,"domain_scores_codex":[0.9994455,0.0002218197,0.00004932678,0.00009317383,0.0001479695,0.00004221776],"domain_scores_gemma":[0.9990569,0.0003302257,0.0003353828,0.00005552247,0.0001041308,0.000117863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1376034,0.000977785,0.2773402,0.004660525,0.01118145,0.0003403554,0.000173765,0.00262975,0.01048724,0.0002917414,0.01402435,0.5402895],"study_design_scores_gemma":[0.02319095,0.0261623,0.9177303,0.0004374527,0.01061633,0.00118321,0.00008472961,0.002020468,0.002151092,0.0003507908,0.0160216,0.00005086781],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9534225,0.03193261,0.001098919,0.001247101,0.0001524361,0.000466652,0.007476076,0.0001062909,0.004097478],"genre_scores_gemma":[0.9808741,0.007673119,0.001351634,0.0008695612,0.000253811,0.0002080225,0.007632526,0.00002786069,0.001109333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002057341,"threshold_uncertainty_score":0.01088041,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008250420486286589,"score_gpt":0.2399584770234168,"score_spread":0.2317080565371302,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}